Showing posts with label cell therapy index. Show all posts
Showing posts with label cell therapy index. Show all posts
Monday, November 19, 2012
Updated cell therapy index portfolio
UPDATED AGAIN DECEMBER 1, 2012 BY ADDING NASDAQ:NWBO
This an update of a post originally released October 18. What has changed is we've added four companies (shown below in red).
...
There are certainly analysts, traders, and brokers who cover the public segment of the cell therapy industry with much more expertise and experience than I -- among them is Henry W. McCusker of Scimitar Equity (@henryw09 on Twitter).
As part of our tracking of the sector's financial data and trends, we have created a portfolio of public cell therapy companies comprised of the 34 companies listed below (linked to their page on Google Finance).
I've been watching this portfolio since the beginning of the calendar year (January 2012) and have been commenting on its performance as against some of the major indices. (Oct 8 post and Aug 10 post).
In addition to these occasional reports I will occasionally report on Twitter (@celltherapyblog) on the stocks in this portfolio which are enjoying the largest gains/losses and which have the largest/smallest trading volumes. From time-to-time I will aggregate this content into a blog post.
Symbol Name
ASTM Aastrom Biosciences, Inc.
ACTC Advanced Cell Technology, Inc.
ABH Angel Biotechnology Holdings Plc
ATHX Athersys, Inc.
AVMXY Avita Medical Ltd
BHRT Bioheart, Inc.
BLFS BioLife Solutions, Inc.
BTX BioTime, Inc.
CBAI Cord Blood America Inc.
CNDO Coronado Biosciences Inc.**
CCEL CRYO-CELL International, Inc.
CMXI Cytomedix, Inc.
CYTX Cytori Therapeutics Inc. (USA)
DNDN Dendreon Corporation
FCSC Fibrocell Science Inc
IMUC ImmunoCellular Therapeutics Ltd
ISCO International Stem Cell Corp
ISLT Islet Sciences Inc
LVCLY Living Cell Technologies **
MEDS Medistem Inc.
MSB Mesoblast limited
MLM Molecular Medicine SpA **
NBS Neostem Inc.
CUR Neuralstem, Inc.
NLNK NewLink Genetics Corp
NWBO Northwest Biotherapeutics, Inc.
OPXA Opexa Therapeutics Inc.
OSIR Osiris Therapeutics, Inc.
PSTI Pluristem Therapeutics Inc.
RENE ReNeuron Group Plc
REPCF RepliCel Life Sciences Inc. **
STEM StemCells, Inc.
TNGN Tengion, Inc.
KOOL ThermoGenesis Corp.
TIG Tigenix NV
** added after original index portfolio was created October 18
Thursday, October 18, 2012
My cell therapy index portfolio
So there are certainly analysts, traders, and brokers who cover the public segment of the cell therapy industry with much more expertise and experience than I. Certainly among the top of this crop is Henry W. McCusker of Scimitar Equity (@henryw09 on Twitter) who is preparing to launch a major new online initiative that I'm very excited about covering the entire regenerative medicine sector focused primarily on the public companies in the sector.
I tend to focus more attention on the activity of private companies in the sector that tend to get a lot less spotlight but as you know I have created a portfolio of public cell therapy companies comprised of the 30 companies listed below (linked to their page on Google Finance).
I've been watching this portfolio since the beginning of the calendar year (January 2012) and have been commenting on its performance as against some of the major indices. (Oct 8 post and August 10 post).
In addition to these occasional reports I will occasionally report on Twitter (@celltherapyblog) on the stocks in this portfolio which are enjoying the largest gains/losses and which have the largest/smallest trading volumes. From time-to-time I will aggregate this content into a blog post.
Subscribe to:
Posts (Atom)